{
  "pmcid": "4357072",
  "config": {
    "model": "gpt",
    "strategy": "zero-shot"
  },
  "usage": {
    "input": 11312,
    "output": 867
  },
  "raw_text": "{\"extractions\":[{\"outcome\":\"improvement in symptom scores\",\"intervention\":\"topical pimecrolimus cream 1%\",\"comparator\":\"triamcinolone acetonide oral paste 0.1%\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":15,\"comparator_events\":null,\"comparator_group_size\":15,\"intervention_mean\":0.2,\"intervention_standard_deviation\":0.4,\"comparator_mean\":0.8,\"comparator_standard_deviation\":0.6},{\"outcome\":\"reduction in burning sensation\",\"intervention\":\"topical pimecrolimus cream 1%\",\"comparator\":\"triamcinolone acetonide oral paste 0.1%\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":15,\"comparator_events\":null,\"comparator_group_size\":15,\"intervention_mean\":1.0,\"intervention_standard_deviation\":2.1,\"comparator_mean\":5.3,\"comparator_standard_deviation\":6.1},{\"outcome\":\"reduction in erythematous area\",\"intervention\":\"topical pimecrolimus cream 1%\",\"comparator\":\"triamcinolone acetonide oral paste 0.1%\",\"outcome_type\":\"binary\",\"intervention_events\":15,\"intervention_group_size\":15,\"comparator_events\":15,\"comparator_group_size\":15,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"reappearance of erythematous areas after 2 months posttreatment\",\"intervention\":\"pimecrolimus\",\"comparator\":\"triamcinolone acetate\",\"outcome_type\":\"binary\",\"intervention_events\":1,\"intervention_group_size\":15,\"comparator_events\":5,\"comparator_group_size\":15,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null}]}",
  "extraction": [
    {
      "outcome": "improvement in symptom scores",
      "intervention": "topical pimecrolimus cream 1%",
      "comparator": "triamcinolone acetonide oral paste 0.1%",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 15,
      "comparator_events": null,
      "comparator_group_size": 15,
      "intervention_mean": 0.2,
      "intervention_standard_deviation": 0.4,
      "comparator_mean": 0.8,
      "comparator_standard_deviation": 0.6,
      "pmcid": "4357072"
    },
    {
      "outcome": "reduction in burning sensation",
      "intervention": "topical pimecrolimus cream 1%",
      "comparator": "triamcinolone acetonide oral paste 0.1%",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 15,
      "comparator_events": null,
      "comparator_group_size": 15,
      "intervention_mean": 1.0,
      "intervention_standard_deviation": 2.1,
      "comparator_mean": 5.3,
      "comparator_standard_deviation": 6.1,
      "pmcid": "4357072"
    },
    {
      "outcome": "reduction in erythematous area",
      "intervention": "topical pimecrolimus cream 1%",
      "comparator": "triamcinolone acetonide oral paste 0.1%",
      "outcome_type": "binary",
      "intervention_events": 15,
      "intervention_group_size": 15,
      "comparator_events": 15,
      "comparator_group_size": 15,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "4357072"
    },
    {
      "outcome": "reappearance of erythematous areas after 2 months posttreatment",
      "intervention": "pimecrolimus",
      "comparator": "triamcinolone acetate",
      "outcome_type": "binary",
      "intervention_events": 1,
      "intervention_group_size": 15,
      "comparator_events": 5,
      "comparator_group_size": 15,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "4357072"
    }
  ]
}